SREBF1 and diabetic kidney disease: For example, both IL-1β and TNF-α are released in high concentrations in IRI, and IL-1β is known to promote renal steatosis in models of diabetic nephropathy through upregulation of SREBP1 in an NLRP3-dependent fashion (Wang C. et al., 2012; Wu et al., 2021).